Literature DB >> 6814427

Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls.

T Momoi, Y Ben-Yoseph, H L Nadler.   

Abstract

The specific activity of acid ceramidase (N-acylsphingosine deacylase, EC 3.5.1.23) was measured at pH4.5 in normal fibroblasts and in fibroblasts from patients with Farber disease and obligate heterozygotes. Greater activity was found when the synthetically made ceramide substrates contained shorter-chain fatty acids or higher content of double bonds. Acid ceramidase activities towards N-lauroyl- (C(12:0)), N-myristoyl- (C(14:0)) and N-palmitoyl- (C(16:0)) sphingosine (C(18:1)) were respectively about 38, 26 and 6 times higher than the activity towards the N-stearoyl (C(18:0)) substrate. The activity towards N-linolenoylsphingosine (C(18:3)/C(18:1)), N-linoleoylsphingosine (C(18:2)/C(18:1)) and N-oleoylsphingosine (C(18:1)/C(18:1)) were respectively about 5, 4 and 3 times higher than the activity towards N-stearoylsphingosine (C(18:0)/C(18:1)). The activity towards N-stearoyldihydrosphingosine (C(18:0)/C(18:0)) was about 40% of that towards N-stearoylsphingosine. Fibroblast alkaline ceramidase possessed significant activity only towards ceramides of unsaturated fatty acids, with a pH optimum of about 9.0. Deficiency of acid ceramidase activity in fibroblasts from patients with Farber disease and intermediate activities in obligate heterozygotes were demonstrated with all ceramides examined except for N-hexanoylsphingosine (C(6:0)/C(18:1)), whereas alkaline ceramidase activity was unaffected. Comparative kinetic studies of acid ceramidase activity with N-lauroylsphingosine and N-oleoylsphingosine demonstrated about 5 (2-12)-fold and 7 (4-17)-fold higher K(m) values in fibroblasts from patients with Farber disease as compared with normal controls. N-Lauroylsphingosine, towards which acid ceramidase activity in control fibroblasts was about 10 times higher than that towards N-oleoylsphingosine, may serve as a better substrate for enzymic diagnosis of Farber disease as well as for further characterization of the catalytically defective acid ceramidase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814427      PMCID: PMC1158496          DOI: 10.1042/bj2050419

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease.

Authors:  M Sugita; P Connolly; J T Dulaney; H W Moser
Journal:  Lipids       Date:  1973-07       Impact factor: 1.880

2.  Farber's lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside.

Authors:  H W Moser; A L Prensky; H J Wolfe; N P Rosman
Journal:  Am J Med       Date:  1969-12       Impact factor: 4.965

3.  The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract.

Authors:  A Nilsson
Journal:  Biochim Biophys Acta       Date:  1969-03-04

4.  Enzymatic hydrolysis of sphingolipids. 8. Further purification and properties of rat brain ceramidase.

Authors:  E Yavin; S Gatt
Journal:  Biochemistry       Date:  1969-04       Impact factor: 3.162

5.  Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase.

Authors:  M Sugita; M Willians; J T Dulaney; H W Moser
Journal:  Biochim Biophys Acta       Date:  1975-07-22

6.  Enzymatic hydrolysis of sphingolipids. I. Hydrolysis and synthesis of ceramides by an enzyme from rat brain.

Authors:  S Gatt
Journal:  J Biol Chem       Date:  1966-08-25       Impact factor: 5.157

7.  Above-normal urinary excretion of urinary ceramides in Farber's disease, and characterization of their components by high-performance liquid chromatography.

Authors:  M Iwamori; H W Moser
Journal:  Clin Chem       Date:  1975-05       Impact factor: 8.327

8.  Ceramides in a patient with lipogranulomatosis (Farber's disease) with chronic course.

Authors:  K Samuelsson; R Zetterström
Journal:  Scand J Clin Lab Invest       Date:  1971-06       Impact factor: 1.713

9.  Ceramidase deficiency in Farber's disease (lipogranulomatosis).

Authors:  M Sugita; J T Dulaney; H W Moser
Journal:  Science       Date:  1972-12-08       Impact factor: 47.728

Review 10.  Biosynthesis and metabolic degradation of sphingolipids not containing sialic acid.

Authors:  P Morell; P Braun
Journal:  J Lipid Res       Date:  1972-05       Impact factor: 5.922

View more
  19 in total

Review 1.  Farber disease: an ultrastructural study. Report of a case and review of the literature.

Authors:  L Zappatini-Tommasi; C Dumontel; P Guibaud; C Girod
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease.

Authors:  Carmen Bedia; Luz Camacho; José Luís Abad; Gemma Fabriàs; Thierry Levade
Journal:  J Lipid Res       Date:  2010-09-24       Impact factor: 5.922

Review 3.  Sphingolipids in the DNA damage response.

Authors:  Brittany Carroll; Jane Catalina Donaldson; Lina Obeid
Journal:  Adv Biol Regul       Date:  2014-11-18

4.  New fluorogenic probes for neutral and alkaline ceramidases.

Authors:  Mireia Casasampere; Núria Bielsa; Daniel Riba; Laura Bassas; Ruijuan Xu; Cungui Mao; Gemma Fabriàs; José-Luis Abad; Antonio Delgado; Josefina Casas
Journal:  J Lipid Res       Date:  2019-03-29       Impact factor: 5.922

5.  Alkaline ceramidase 2 (ACER2) and its product dihydrosphingosine mediate the cytotoxicity of N-(4-hydroxyphenyl)retinamide in tumor cells.

Authors:  Zhehao Mao; Wei Sun; Ruijuan Xu; Sergei Novgorodov; Zdzislaw M Szulc; Jacek Bielawski; Lina M Obeid; Cungui Mao
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

6.  Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression.

Authors:  Natasha C Lucki; Sibali Bandyopadhyay; Elaine Wang; Alfred H Merrill; Marion B Sewer
Journal:  Mol Endocrinol       Date:  2012-01-19

Review 7.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

8.  Bone marrow involvement and obstructive jaundice in Farber lipogranulomatosis: clinical and autopsy report of a new case.

Authors:  M J Nowaczyk; A Feigenbaum; M M Silver; J Callahan; A Levin; V Jay
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

9.  Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes.

Authors:  Ruijuan Xu; Wei Sun; Junfei Jin; Lina M Obeid; Cungui Mao
Journal:  FASEB J       Date:  2010-03-05       Impact factor: 5.191

Review 10.  Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.

Authors:  Cungui Mao; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2008-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.